Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial (Diabetes, Obesity and Metabolism, 2019)

(untitled) - Ohkuma, T; Zoungas, S; Jun, M; Lisheng, L; Mancia, G; Marre, M; Rodgers, A; Williams, B; Woodward, M; Chalmers, J